Conformationally Regulated Peptide Bond Cleavage in Bradykinin

Daniel R. Fuller, Christopher Conant, Tarick J. El‐Baba, Christopher J. Brown, Daniel W. Woodall, David H. Russell, David E. Clemmer

Journal of the American Chemical Society · 2018 · 27 citations · 23 references

Concepts

Abstract

Ion mobility and mass spectrometry techniques are used to investigate the stabilities of different conformations of bradykinin (BK, Arg1-Pro2-Pro3-Gly4-Phe5-Ser6-Pro7-Phe8-Arg9). At elevated solution temperatures, we observe a slow protonation reaction, i.e., [BK+2H]2++H+ → [BK+3H]3+, that is regulated by trans → cis isomerization of Arg1-Pro2, resulting in the Arg1-cis-Pro2-cis-Pro3-Gly4-Phe5-Ser6-cis-Pro7-Phe8-Arg9 (all-cis) configuration. Once formed, the all-cis [BK+3H]3+ spontaneously cleaves the bond between Pro2-Pro3 with perfect specificity, a bond that is biologically resistant to cleavage by any human enzyme. Temperature-dependent kinetics studies reveal details about the intrinsic peptide processing mechanism. We propose that nonenzymatic cleavage at Pro2-Pro3 occurs through multiple intermediates and is regulated by trans → cis isomerization of Arg1-Pro2. From this mechanism, we can extract transition state thermochemistry: ΔG‡ = 94.8 ± 0.2 kJ·mol–1, ΔH‡ = 79.8 ± 0.2 kJ·mol–1, and ΔS‡ = −50.4 ± 1.7 J·mol–1·K–1 for the trans → cis protonation event; and, ΔG‡ = 94.1 ± 9.2 kJ·mol–1, ΔH‡ = 107.3 ± 9.2 kJ·mol–1, and ΔS‡ = 44.4 ± 5.1 J·mol–1·K–1 for bond cleavage. Biological resistance to the most favored intrinsic processing pathway prevents formation of Pro3-Gly4-Phe5-Ser6-cis-Pro7-Phe8-Arg9 that is approximately an order of magnitude more antigenic than BK.

References

23